Candel Therapeutics Inc. (NASDAQ: CADL) Stock Information | RedChip

Candel Therapeutics Inc. (NASDAQ: CADL) Listen to this Section


$5.28
-0.1000 ( -1.86% ) 131.0K

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Market Data


Open


$5.28

Previous close


$5.38

Volume


131.0K

Market cap


$169.09M

Day range


$5.27 - $5.57

52 week range


$0.66 - $14.30

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Apr 09, 2024
8-k 8K-related 13 Apr 04, 2024
8-k 8K-related 15 Mar 28, 2024
10-k Annual reports 90 Mar 28, 2024
8-k 8K-related 14 Mar 06, 2024
8-k 8K-related 14 Feb 13, 2024
3 Insider transactions 2 Jan 19, 2024
8-k 8K-related 10 Jan 12, 2024
8-k 8K-related 12 Jan 03, 2024
8-k 8K-related 12 Dec 15, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.